BioSpace News Archive

Aerie Pharmaceuticals, Inc. announced today that its third quarter 2021 financial results will be released after the market closes on Thursday, November 4, 2021.

Repligen Corporation today reported financial results for its third quarter of 2021.

Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that it will report third quarter 2021 financial results and provide a corporate update before market open on Thursday, November 4, 2021.

CytomX Therapeutics, Inc. (Nasdaq: CTMX), today announced that it will report third quarter 2021 financial results on Thursday, November 4, 2021, after the close of U.S. markets.

Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced the appointment of Carmen Volkart to its Board of Directors.

CinCor Pharma, Inc. announced the appointment of Terry Coelho as Executive Vice President, Chief Financial Officer and Chief Business Development Officer.

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that management will report third quarter 2021 financial results before the market opens on November 4, 2021.

(“Providence”) announces Donna T. Ward, Ph.D., J.D. appointment to Board of Directors.

AbbVie today announced that continuous 24 hours/day subcutaneous infusion of ABBV-951 was statistically superior to oral levodopa/carbidopa in reducing motor fluctuations in patients with advanced Parkinson’s disease (PD) in a Phase 3, randomized, double-blind, double-dummy, active-controlled study.

The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 47 cents per share of common stock.